Denosumab increases risk of severe hypocalcemia in women with osteoporosis and chronic kidney disease
1. In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment as compared with bisphosphonates among women with osteoporosis in the setting of chronic kidney disease (CKD). 2. The risk of developing...